학술논문

DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/β-catenin signaling
Document Type
article
Source
Molecular Psychiatry. 23(2)
Subject
Biological Psychology
Pharmacology and Pharmaceutical Sciences
Biomedical and Clinical Sciences
Psychology
Serious Mental Illness
Schizophrenia
Behavioral and Social Science
Brain Disorders
Mental Health
Neurosciences
2.1 Biological and endogenous factors
Aetiology
Mental health
Animals
Anxiety
Anxiety Disorders
Dendritic Spines
Depression
Depressive Disorder
Glutamate Plasma Membrane Transport Proteins
Glycogen Synthase Kinase 3
Intracellular Signaling Peptides and Proteins
Mental Disorders
Mice
Mice
Knockout
Polymorphism
Single Nucleotide
Pyramidal Cells
Social Behavior
Synapses
Wnt Signaling Pathway
beta Catenin
Biological Sciences
Medical and Health Sciences
Psychology and Cognitive Sciences
Psychiatry
Clinical sciences
Biological psychology
Clinical and health psychology
Language
Abstract
Mice lacking DIX domain containing-1 (DIXDC1), an intracellular Wnt/β-catenin signal pathway protein, have abnormal measures of anxiety, depression and social behavior. Pyramidal neurons in these animals' brains have reduced dendritic spines and glutamatergic synapses. Treatment with lithium or a glycogen synthase kinase-3 (GSK3) inhibitor corrects behavioral and neurodevelopmental phenotypes in these animals. Analysis of DIXDC1 in over 9000 cases of autism, bipolar disorder and schizophrenia reveals higher rates of rare inherited sequence-disrupting single-nucleotide variants (SNVs) in these individuals compared with psychiatrically unaffected controls. Many of these SNVs alter Wnt/β-catenin signaling activity of the neurally predominant DIXDC1 isoform; a subset that hyperactivate this pathway cause dominant neurodevelopmental effects. We propose that rare missense SNVs in DIXDC1 contribute to psychiatric pathogenesis by reducing spine and glutamatergic synapse density downstream of GSK3 in the Wnt/β-catenin pathway.